Your browser doesn't support javascript.
loading
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik, Roger; Müller Herde, Adrienne; Haider, Ahmed; Krämer, Stefanie D; Weber, Markus; Schibli, Roger; Ametamey, Simon M; Mu, Linjing.
Afiliação
  • Slavik R; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Müller Herde A; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Haider A; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Krämer SD; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Weber M; Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Schibli R; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland.
  • Ametamey SM; Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Mu L; Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland. simon.ametamey@pharma.ethz.ch.
J Neurochem ; 138(6): 874-86, 2016 09.
Article em En | MEDLINE | ID: mdl-27385045

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Adamantano / Quinolonas / Compostos Radiofarmacêuticos / Receptor CB2 de Canabinoide / Tomografia por Emissão de Pósitrons Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Adamantano / Quinolonas / Compostos Radiofarmacêuticos / Receptor CB2 de Canabinoide / Tomografia por Emissão de Pósitrons Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article